The trajectory of Viagra presents a interesting case for stakeholders in the pharmaceutical sector. While initially a tremendous success, creating billions, the exclusivity lapse and the subsequent arrival of off-brand competitors website have drastically impacted revenue. This poses questions about the future viability of analogous therapeutic inn